Immunovia announces positive outcome and strong accuracy in the clinical validation of its next-generation test for pancreatic cancer ...Middle East

PR Newswire - News
LUND, Sweden, Dec. 9, 2024 /PRNewswire/ -- Immunovia (STO: IMMNOV), the pancreatic cancer diagnostics company, today announces the successful completion of the CLARITI study, (Clinical Validation of Next-Generation Test for Early-Stage Pancreatic Cancer) to detect early-stage pancreatic...

Hence then, the article about immunovia announces positive outcome and strong accuracy in the clinical validation of its next generation test for pancreatic cancer was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunovia announces positive outcome and strong accuracy in the clinical validation of its next-generation test for pancreatic cancer )

Apple Storegoogle play

Last updated :

Also on site :



Latest News